M. Gokce et al., 5-FU LOADED PHEMA DRAINAGE IMPLANTS FOR GLAUCOMA-FILTERING SURGERY - DEVICE DESIGN AND IN-VITRO RELEASE KINETICS, Biomaterials, 17(9), 1996, pp. 941-949
Implantable monolithic and reservoir-like water-swellable drainage dev
ices were developed for the subconjunctival sustained release of 5-flu
orouracil (5-FU) in glaucoma-filtering surgery. A water-swellable matr
ix was formed of a copolymer of 2-hydroxyethyl methacrylate (HEMA) wit
h different amounts of ethylene glycol dimethacrylate (EGDMA). Drug in
corporation was done before polymerization and cross-linking. Briefly,
to prepare the monolithic device the monomer-drug mixture is compress
ion moulded into a 10 mm cylinder of 1 mm length. Furthermore, reservo
ir-like devices were obtained by coating the monolithic devices with a
highly cross-linked polymer of HEMA (pHEMA) composition. The pHEMA de
vices containing 5-FU or not were well characterized by means of dynam
ic swelling studies, structural and thermal analysis. The release of 5
-FU from these implants was studied in vitro. The rate of drug release
was controlled by changing the drug loading (i.e. 10 mg or 20 mg 5-FU
per device), cross-linking density of polymer matrix and type of impl
antable device, i.e. monolithic or reservoir-like device. While monoli
thic devices are releasing total releasable 5-FU during the first 10 h
, reservoir-like devices prolong 5-FU release for up to 120 h. The 5-F
U diffusion coefficient in swollen devices (D-s,D-s) is in the order o
f 10(-8) cm(2) s(-1) (approximately 10 times smaller than D-w,D-g valu
es) and it is dependent on the cross-linking density of polymeric matr
ix and device load. These preliminary results suggested that 20 mg 5-F
U-loaded reservoir-like devices may be a potentially effective system
to deliver 5-FU into the subconjunctiva.